Pavan Lall And Sohini Das

Stories by Pavan Lall And Sohini Das

Kodiaq, Skoda's brand-new luxury SUV, stands tall among 7-seaters

Kodiaq, Skoda's brand-new luxury SUV, stands tall among 7-seaters

Rediff.com   28 Feb 2022

Suspension that has fully acclimatised to Indian roads and handles potholes and bumps with ease, plush interiors that feel premium beyond just surface level, and aggressive and imposing design cues give this SUV a presence and profile that has little competition, says Pavan Lall.

India Inc braces for fallout of Russia-Ukraine crisis

India Inc braces for fallout of Russia-Ukraine crisis

Rediff.com   23 Feb 2022

Stocks of Indian companies with exposure to Europe fell on Tuesday amid concerns about the impact on their sales in case the Russia-Ukraine crisis worsens and the US and its allies impose economic sanctions on Russia. While top conglomerates, including Reliance Industries, the Tata group, and Aditya Birla Group, said they did not have any significant exposure to Russia, executives of some of the oil and gas, pharmaceutical, and tea companies said they were monitoring the situation closely as they earned substantial income from the region. Russian President Vladimir Putin on Monday ordered troops into two breakaway regions of eastern Ukraine after announcing that Russia would recognise their independence.

Audi's 3 mantras to set it apart from the competition

Audi's 3 mantras to set it apart from the competition

Rediff.com   8 Feb 2022

Audi's strategy seems to point to pushing technology to directly connect with consumers using digital platforms and marketing to synchromesh into one seamless experience, says Pavan Lall.

Number of Covid symptomatic kids jump, post-recovery issues a concern

Number of Covid symptomatic kids jump, post-recovery issues a concern

Rediff.com   14 Jan 2022

While the infection has been mild in most reported cases, those below two years of age are showing signs of acute infection.

'We have to ensure vaccines work against new variants'

'We have to ensure vaccines work against new variants'

Rediff.com   11 Jan 2022

Adar Poonawalla says it took a five-minute chat with his father Cyrus before making the decision to manufacture Covishield. The bet paid off, and handsomely. Serum Institute now has the capacity to make 4 billion doses of Covishield annually.

Covaxin shelf life extended, Bharat Biotech relabels old stocks

Covaxin shelf life extended, Bharat Biotech relabels old stocks

Rediff.com   5 Jan 2022

The company had in December said that the CDSCO had approved a 12-month shelf life for Covaxin, which was nine months earlier, Sohini Das reports.

Does India have enough jabs to expand vaccination drive?

Does India have enough jabs to expand vaccination drive?

Rediff.com   3 Jan 2022

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.

Relaunched Honda Amaze looks like a brand new car

Relaunched Honda Amaze looks like a brand new car

Rediff.com   3 Jan 2022

It's a zippy, well-engineered ride that offers comfort, quality, low cost of ownership and fuel efficiency at affordable prices, says Pavan Lall.

Covishield accounts for 88% of Covid jabs in India

Covishield accounts for 88% of Covid jabs in India

Rediff.com   1 Jan 2022

Serum Institute has the capacity to make 250 million doses of Covishield monthly.

Covaxin safe for children: Bharat Biotech

Covaxin safe for children: Bharat Biotech

Rediff.com   31 Dec 2021

Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

Rediff.com   28 Dec 2021

'Antibodies remain in the blood for at least seven to nine months.'

Are You Eligible For A Booster Shot?

Are You Eligible For A Booster Shot?

Rediff.com   27 Dec 2021

'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com   24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

'India is one of Starbucks' top 5 fastest-growing markets'

'India is one of Starbucks' top 5 fastest-growing markets'

Rediff.com   22 Dec 2021

'We were taking the Starbucks experience from the store to the home.'

Volkswagen Rolls Out Tiguan

Volkswagen Rolls Out Tiguan

Rediff.com   18 Dec 2021

Through a combination of local manufacture and imported CBU models, the company makes and sells four SUVs, one hatchback, and one sedan.

After discontinuing it in 2020, Audi brings back A4

After discontinuing it in 2020, Audi brings back A4

Rediff.com   13 Dec 2021

And it feels entirely different when compared to all its earlier avatars, observes Pavan Lall.

India's vaccine makers prepare to take on Omicron

India's vaccine makers prepare to take on Omicron

Rediff.com   8 Dec 2021

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.

Health expenditure's share in GDP down

Health expenditure's share in GDP down

Rediff.com   7 Dec 2021

The share of total health expenditure as part of the gross domestic product (GDP) went down to 3.3 per cent in 2017-18 from 3.8 per cent in the previous two years, according to the national health account data released on Monday by the health ministry. The share of government expenditure as part of total expenditure as well as GDP has gone up from from 3.78 per cent to 5.12 per cent between 2013-14 and 2017-18, which could also explain a decline seen in out of pocket expenditure in 2017-18. Health ministry also emphasised the increase in the government health expenditure as part of the total GDP from 1.15 per cent in 2013-14 to 1.35 per cent in 2017-18.

Nearly 33% of India's medical devices capacity lying unused

Nearly 33% of India's medical devices capacity lying unused

Rediff.com   7 Dec 2021

After ramping up production to meet the steep demand spike during the Covid-19 pandemic, Indian medical device makers are now struggling with idle capacity. According to industry estimates, around a third of the installed capacity, especially for consumables, disposables, small-ticket electronic items, etc., is lying unutilised. Sample this: India used to produce just 6.24 million pieces of PPE kits per annum before the pandemic, but by June this was ramped up to 233.87 million pieces per annum.

Meet The Man behind Skoda VW India

Meet The Man behind Skoda VW India

Rediff.com   7 Dec 2021

'Approach people with respect, mindful that they know their job better than you do, and that you're not superior to them just because you may be better educated or their boss.' Skoda Auto VW India MD Gurpratap S Boparai cites his management credo to Pavan Lall.